InvestorsObserver
×
News Home

Should You Buy Satsuma Pharmaceuticals Inc (STSA) Stock?

Friday, January 15, 2021 03:03 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Satsuma Pharmaceuticals Inc (STSA) Stock?

Satsuma Pharmaceuticals Inc (STSA) stock has fallen -70.71% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives STSA stock a score of 19 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 2. STSA's rank also includes a short-term technical score of 22. The fundamental score for STSA is 31. In addition to the average rating from Wall Street analysts, STSA stock has a mean target price of 5. This means analysts expect the stock to lose 10.07% over the next 12 months.

Overall Score - 19
STSA has an Overall Score of 19. Find out what this means to you and get the rest of the rankings on STSA!

What's Happening with STSA Stock Today

Satsuma Pharmaceuticals Inc (STSA) stock is higher by 10.56% while the S&P 500 has fallen -0.46% as of 3:01 PM on Friday, Jan 15. STSA is up $0.53 from the previous closing price of $5.03 on volume of 339,966 shares. Over the past year the S&P 500 has gained 13.90% while STSA has fallen -70.71%. STSA lost -$2.64 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Satsuma Pharmaceuticals Inc (STSA) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App